<DOC>
	<DOCNO>NCT00004690</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare safety efficacy monolaurin cream versus placebo vehicle cream suppress sign nonbullous congenital ichthyosiform erythroderma . II . Assess incidence posttreatment rebound recrudescence patient congenital ichthyosis . III . Evaluate long term safety monolaurin cream whole body application patient .</brief_summary>
	<brief_title>Phase III Study Monolaurin Cream Therapy Patients With Congenital Ichthyosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This three month , randomize , double blind , placebo control study follow nine month , open label , rollover study . Patients treat either placebo vehicle cream study cream , monolaurin ( 15 % glyceryl monolaurate ) , 3 month follow four week break . Medications apply uniformly twice daily ( morning least 1 hour bedtime ) . After blind portion study , patient administer monolaurin cream 9 month . Patients follow 4 week last cream application . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Ichthyosis</mesh_term>
	<mesh_term>Monolaurin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Nonbullous congenital ichthyosiform erythroderma ( chronic , multifactorial , hyperkeratotic , inflammatory skin disease ) Clinical criterion include : generalize involvement flexural spar congenital onset usually collodion baby ( i.e. , taut , shiny encasement shed postnatally reveal underlie erythroderma generalize ichthyosis ) scale fine , whitish , rather loose except low leg scale may large , platelike , dark severely effect : intense erythema present ; overt ectropion may present ; cicatricial alopecia may present ; secondary nail dystrophy thicken nail plate ridging may present Phenotypically consistent diagnostic grading photo Grade least 3 scale four treatment site Prior/Concurrent Therapy Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : At least 4 week since prior corticosteroid No concurrent corticosteroid Radiotherapy : Not specify Surgery : Not specify Other : At least 4 week since prior investigational medication At least 4 week since prior systemic therapy , hypolipidemics retinoids Nonglycerin emollient allow 1 week prior study At least 4 week since topical therapy include humectant urea , alpha hydroxy alpha ketoacid preparation retinoids No concurrent topical therapy No concurrent investigational medication Patient Characteristics Age : 18 month Performance status : Not specify Hematopoietic : No clinically significant laboratory abnormality Hepatic : No clinically significant laboratory abnormality Renal : No clinically significant laboratory abnormality Other : Triglyceride total cholesterol great 3 time normal Must general good health No known hypersensitivity component study medication Not pregnant nursing Adequate contraception require fertile woman</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1999</verification_date>
	<keyword>dermatologic disorder</keyword>
	<keyword>ichthyosis</keyword>
	<keyword>rare disease</keyword>
</DOC>